查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466143

去腎神經設備市場：按技術、產品、疾病應用和最終用戶分類 - 全球預測 2024-2030

Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Nerve Modifying Agents, RF Generator), Disease Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

腎臟去神經設備市場規模預計2023年為2.3629億美元，2024年達2.6644億美元，預計2030年將達到5.7985億美元，複合年成長率為13.68%。

去腎交感神經裝置是醫療設備。這些設備透過針對腎動脈周圍多餘的交感神經提供了另一種解決方案，腎動脈在調節血壓方面發揮關鍵作用，並有助於高血壓的發展。由於生活方式的改變，全球人群難治性高血壓的盛行率不斷增加，人們越來越意識到去腎神經術相對於傳統藥物治療的好處，以及老年人口的增加正在推動去腎神經術設備市場的成長。然而，去腎神經裝置、相關程序和一些嚴格的法律規範的高成本可能會阻礙市場成長。設備設計和技術方面的技術進步正在提高腎去神經術治療的功效和安全性，並有望創造利潤豐厚的市場機會。

主要市場統計
基準年[2023] 2.3629億美元
預測年份 [2024] 26644萬美元
預測年份 [2030] 57985萬美元
複合年成長率（%） 13.68%

技術：基於超音波的腎臟去神經技術的採用率很高

基於微量輸注的腎去神經術涉及將少量抗高血壓藥物直接注入腎動脈周圍的空間。這種有針對性的方法可以最大限度地減少全身副作用並提高藥物療效。藥物消融使用神經毒性藥物（例如酒精或胍乙啶）以化學方式破壞過度活躍的腎臟神經。當由於解剖複雜性或禁忌症而無法採用射頻或超音波方法時，首選此手術。射頻腎去神經術涉及應用受控電能來破壞目標腎神經。該方法因其準確性、安全性和降低血壓的有效性而受到青睞。基於超音波的腎去神經術使用高頻聲波產生局部熱量來破壞過度活躍的腎神經。這種非侵入性方法對於有禁忌症或對其他方法過敏的患者很有吸引力。

產品多電極導管因其手術時間短而被廣泛使用。

導管是腎臟去神經手術中使用的主要設備，它提供射頻能源來消融或改變引起高血壓的神經。導管主要用於其微創性和針對特定神經的精確性。多電極導管的尖端有多個電極，可以同時消融多個神經部位，這可能會減少手術時間並提高療效。神經調節劑是與腎臟去神經裝置搭配使用的藥物，可改善手術結果。這些藥物可改善患者的整體反應或最大程度地減少手術中可能出現的併發症。 RF（射頻）產生器是腎臟去神經手術中使用的重要設備，可將受控能量傳遞到消融神經的導管。單電極導管的尖端有一個電極，用於順序消融神經部位。這些導管可以更精確地瞄準特定神經，但該過程可能比多電極導管花費更長的時間。

疾病應用：擴大去腎神經裝置在高血壓治療的應用

去腎神經裝置已成為糖尿病合併高血壓和腎臟病病患者的有效治療方法。去腎神經裝置可抑制交感神經的過度活躍，進而加劇糖尿病併發症。在心臟衰竭患者中，交感神經活動增加，導致血壓升高和體液超負荷，這是腎臟損傷進展的因素。去腎神經治療可以有效抑制這些患者的交感神經亢進，改善心臟功能和整體生活品質。在高血壓中，去腎神經支配透過損害腎交感神經並減少其對血壓調節的影響來幫助降低血壓。去腎神經裝置被認為是慢性腎臟病（CKD）患者的潛在治療選擇，這些患者經常患有高血壓和糖尿病併發症。這種調節交感神經系統的治療方法可能有助於減緩 CKD 的進展並減輕與腎功能障礙相關的症狀。

最終用戶：門診醫療中心偏好去腎神經裝置作為微創且經濟高效的解決方案

門診護理中心 (ACC) 是一家門診設施，提供各種醫療服務，包括腎臟相關疾病的診斷和治療，並為高血壓患者的管理提供去腎神經裝置。 ACC 青睞微創、經濟高效的解決方案，以確保患者的安全和舒適，同時最大限度地提高業務效率。診斷中心和醫院對於透過早期發現和介入來控制高血壓至關重要。隨著全球範圍內不受控制的高血壓和抗藥性病例的增加，這些設施需要先進的去腎神經設備來最佳化患者的治療效果。醫院在選擇去腎神經裝置時優先考慮易用性、對現有設備的適應性以及強大的臨床資料支援。研究機構和學術中心處於高血壓治療的最前沿，開發腎臟去神經術的新治療方法和設備。這些組織專注於具有強力臨床證據的最尖端科技，以支持該領域的未來發展。

區域洞察

市場狀況很重要，因為美洲人口中高血壓盛行率很高，並且在新治療方法的研究上投入了大量資金。技術的進步和醫療保健專業人員對創新治療方法的認知不斷提高正在推動對這些設備的需求。由於各國對去腎神經療法的認知不斷提高以及有利的報銷政策，歐盟顯示出巨大的市場成長潛力。高血壓預防和管理方面的合作正在加速該領域的研究和開發舉措。由於高血壓盛行率不斷上升，加上生活方式的改變和都市化，中東和非洲地區是去腎神經裝置的一個前景廣闊的市場。在亞太地區，由於政府對高血壓研究的資助和舉措，臨床試驗和專利申請的數量正在增加。強大的醫療基礎設施、對技術進步的濃厚興趣、高血壓管理意識的提高以及醫療設施的改善正在促進該地區去腎神經設備市場的成長。

FPNV定位矩陣

FPNV定位矩陣對於評估去腎神經裝置市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對腎去神經設備市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.去腎神經裝置市場的市場規模和預測是多少？

2.在腎臟去神經設備市場預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.去腎神經器材市場的技術趨勢和法規結構是什麼？

4.去腎神經設備市場主要供應商的市場佔有率是多少？

5. 進入去腎神經器材市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著人口老化，慢性腎衰竭的盛行率不斷增加
      • 微創手術的日益普及與趨勢
    • 抑制因素
      • 與去腎神經裝置相關的高成本
    • 機會
      • 腎臟去神經裝置的技術進步與改進
      • 繼續出版腎去神經術的臨床指引和越來越多的臨床評估研究
    • 任務
      • 關於產品核可的嚴格政府法規和缺乏經驗豐富的醫療保健專業人員
  • 市場區隔分析
    • 技術：超音波腎神經切除技術採用率高
    • 產品：增加多電極導管的使用以減少手術時間
    • 疾病應用：增加去腎神經裝置在高血壓治療的使用
    • 最終用戶：門診護理中心偏好去腎神經裝置作為微創且經濟高效的解決方案。
  • 市場趨勢分析
    • 在美洲，由於醫療設備製造商的存在以及醫療專業人員日益成長的支持，政府對去腎神經設備的核准一直很有利。
    • 擴大政府支持以改善高血壓的診斷和治療，並增加亞太地區去腎臟神經裝置臨床試驗的正面結果
    • 支持全部區域腎神經裝置的政府措施和核准流程
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章去腎臟神經設備市場：依技術分類

  • 微輸液底座
  • 藥物消融
  • 射頻基地
  • 超音波基地

第7章腎臟去神經設備市場：依產品

  • 導管
  • 神經調節劑
  • 射頻發生器

第8章去腎神經裝置市場依疾病分類的應用

  • 糖尿病
  • 心臟衰竭
  • 高血壓
  • 腎衰竭

第9章去腎神經裝置市場：依最終用戶分類

  • 門診治療中心
  • 診斷中心和醫院
  • 研究和學術

第10章美洲去腎神經裝置市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太去腎臟神經設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲去腎神經裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Record Medical 和 Otsuka Medical Devices 宣布推出首個獲得 FDA核准的用於高血壓治療的腎臟去神經系統
    • FDA核准Verve Medical 的 IDE 腎盂去神經術研究
    • 韓國Start-UpsKalos 獲得 350 萬美元津貼，用於開發治療高血壓的去腎神經裝置
    • 德國正在進行超音波術抗治療性高血壓的早期療效評估
    • Andera Partners 投資了一家醫療技術公司 SoniVie，該公司正在開發一種有前途的治療高血壓的設備
    • 法國Medtronic生產的腎臟去神經導管 SYMPLICITY SPYRAL 過渡蓋
    • 上海金葉醫療科技有限公司獲數百萬人民幣C輪融資
    • SPYRAL HTN-ON MED 試驗證明了有意義的臨床益處，與其他 SPYRAL HTN 腎臟去神經試驗一致
    • Sonivee 獲得 FDA 的 IDE核准，用於使用腎動脈神經阻斷 TIVUS 技術治療高血壓的先驅性研究
    • Ablative Solutions 在 D 輪資金籌措中籌集了 9,140 萬美元
    • Clinical Accelerator 宣布與 Verve Medical 合作進行抗治療性的早期人體可行性研究

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-957C47F91FC5

[192 Pages Report] The Renal Denervation Devices Market size was estimated at USD 236.29 million in 2023 and expected to reach USD 266.44 million in 2024, at a CAGR 13.68% to reach USD 579.85 million by 2030.

Renal denervation devices are medical tools that provide minimally invasive therapy for patients suffering from drug-resistant hypertension or high blood pressure that do not respond adequately to conventional pharmacological therapies. These devices offer an alternative solution by targeting the overactive sympathetic nerves surrounding the renal arteries, which play a crucial role in regulating blood pressure and contribute to the development of hypertension. The increasing prevalence of resistant hypertension among the global population due to lifestyle changes, rising awareness about the benefits of renal denervation procedures over conventional drug therapies, and the growing geriatric population are driving the renal denervation devices market growth. However, the high cost of renal denervation devices, associated procedures, and several stringent regulatory frameworks may hamper market growth. Technological advancements in device design and procedural techniques have improved efficacy and safety profiles for renal denervation treatments, which is expected to create a lucrative market opportunity.

KEY MARKET STATISTICS
Base Year [2023] USD 236.29 million
Estimated Year [2024] USD 266.44 million
Forecast Year [2030] USD 579.85 million
CAGR (%) 13.68%

Technology: High adoption of ultrasound-based renal denervation technology

Micro-infusion-based renal denervation involves delivering small doses of anti-hypertensive drugs directly into the periarterial space surrounding the renal arteries. This targeted approach minimizes systemic side effects and improves drug efficacy. Pharmacologic ablation involves chemically destroying overactive renal nerves using neurotoxic agents such as alcohol or guanethidine. This technique is preferred when radiofrequency or ultrasound-based approaches are not feasible due to anatomical complexities or contraindications. Radiofrequency-based renal denervation involves applying controlled electrical energy to destroy targeted renal nerves. This method is preferred for its precision, safety, and effectiveness in reducing blood pressure. Ultrasound-based renal denervation uses high-frequency sound waves to generate localized heat that disrupts overactive renal nerves. This non-invasive technique makes it attractive for patients with contraindications or sensitivities to other methods.

Product: Significant use of multi-electrode catheters for their shorter-time of procedures

Catheters are the primary device used in renal denervation procedures to deliver radiofrequency energy to ablate or modify nerves responsible for hypertension. They are primarily used for their minimally invasive nature and precision in targeting specific nerves. Multi-electrode catheters have multiple electrodes on the tip that enable simultaneous ablation of multiple nerve sites, reducing procedure time and potentially increasing efficacy. Nerve-modifying agents are pharmaceuticals that work alongside renal denervation devices to enhance procedural outcomes. These agents may improve overall patient response or minimize potential complications arising from the procedure. An RF (Radiofrequency) generator is an essential device used in renal denervation procedures for providing controlled energy to catheters to ablate nerves. Single electrode catheters feature a single electrode at the tip and are used for sequential ablation of nerve sites. These catheters offer greater precision in targeting specific nerves but may require longer procedures than multi-electrode variants.

Disease Application: Proliferating use of renal denervation devices for treating hypertension

Renal denervation devices have emerged as an effective treatment for diabetic patients suffering from hypertension and nephropathy. These devices modulate the overactive sympathetic nervous system responsible for worsening diabetic complications. Heart failure patients experience high sympathetic activity, leading to increased blood pressure and fluid overload factors contributing to progressive kidney damage. Renal denervation therapy can effectively reduce sympathetic hyperactivity in these patients, improving cardiac function and overall quality of life. In hypertension, renal denervation helps lower blood pressure by disrupting the renal sympathetic nerves, reducing their influence on blood pressure regulation. Renal denervation devices are being explored as a potential treatment option for chronic kidney disease (CKD) patients who often suffer from hypertension and diabetic complications. The therapy's ability to modulate the sympathetic nervous system may help slow CKD progression and alleviate symptoms associated with kidney dysfunction.

End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution

Ambulatory care centers (ACCs) are outpatient facilities that provide various medical services, including diagnosis and treatment for kidney-related diseases, and offer renal denervation devices to manage patients with hypertension. ACCs prefer minimally invasive and cost-effective solutions to ensure patient safety and comfort while maximizing operational efficiency. Diagnostic centers and hospitals are crucial in managing hypertension through early detection and intervention. With a growing global prevalence of uncontrolled hypertension and drug-resistant cases, these institutions require advanced renal denervation devices for optimal patient outcomes. Hospitals prioritize ease of use, adaptability with existing equipment, and robust clinical data support when selecting renal denervation devices. Research institutions and academic centers are at the forefront of hypertension management, developing novel therapies and devices for renal denervation. These organizations focus on cutting-edge technology with strong clinical evidence to support future advancements in the field.

Regional Insights

The Americas has a significant landscape in the renal denervation devices market due to a high prevalence of hypertension among its population and substantial investments in research for novel therapies. Advancements in technology and growing awareness about innovative treatment options amongst healthcare professionals have fueled demand for these devices. The EU shows significant potential for market growth owing to increased awareness about renal denervation therapy and favorable reimbursement policies across countries. Collaborative efforts on hypertension prevention and control have accelerated R&D initiatives in this domain. The MEA region holds promising opportunities for renal denervation devices due to a rising incidence of hypertension coupled with lifestyle changes and urbanization. In the APAC region, government funding and initiatives for hypertension research resulted in a growing number of clinical trials and patent filings. Robust healthcare infrastructure, a strong focus on technological advancements, increased awareness about hypertension management, and improved healthcare facilities have contributed to the region's renal denervation devices market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Renal Denervation Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Renal Denervation Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., AngioDynamics, Inc., Aria CV, Inc., AtriCure, Inc., Bio-Heart, Boston Scientific Corporation, Cardinal Health, Inc., Kalos Medical, Medtronic PLC, Mercator MedSystems, Inc., Otsuka Holdings Co., Ltd., Shanghai Meiliweiye Medical Technology Co., Ltd., SoniVie, Symap Medical, Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Micro-Infusion-Based
    • Pharmacologic Ablation
    • Radiofrequency-Based
    • Ultrasound-Based
  • Products
    • Catheters
      • Multi Electrode Catheter
      • Single Electrode Catheter
    • Nerve Modifying Agents
    • RF Generator
  • Disease Application
    • Diabetes
    • Heart Failure
    • Hypertension
    • Renal Failure
  • End-User
    • Ambulatory Care Centers
    • Diagnostic Centers & Hospitals
    • Research & Academia
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Renal Denervation Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Renal Denervation Devices Market?

3. What are the technology trends and regulatory frameworks in the Renal Denervation Devices Market?

4. What is the market share of the leading vendors in the Renal Denervation Devices Market?

5. Which modes and strategic moves are suitable for entering the Renal Denervation Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of congestive chronic renal failure with aging population
      • 5.1.1.2. Growing adoption and inclination towards minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with renal denervation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and improvements in renal denervation devices
      • 5.1.3.2. Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations for product approval coupled with lack of experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: High adoption of ultrasound-based renal denervation technology
    • 5.2.2. Product: Significant use of multi-electrode catheters for their shorter-time of procedures
    • 5.2.3. Disease Application: Proliferating use of renal denervation devices for treating hypertension
    • 5.2.4. End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution
  • 5.3. Market Trend Analysis
    • 5.3.1. Favorable government approvals for renal denervation devices in the Americas backed by the presence of well-established medical device companies and rising medical professional acceptance
    • 5.3.2. Expanding government support to improve diagnosis and treatment of hypertension coupled with increasing positive results from clinical trials of renal denervation devices in the APAC region
    • 5.3.3. Supportive government initiatives and approval procedures for renal denervation devices across the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Renal Denervation Devices Market, by Technology

  • 6.1. Introduction
  • 6.2. Micro-Infusion-Based
  • 6.3. Pharmacologic Ablation
  • 6.4. Radiofrequency-Based
  • 6.5. Ultrasound-Based

7. Renal Denervation Devices Market, by Products

  • 7.1. Introduction
  • 7.2. Catheters
  • 7.3. Nerve Modifying Agents
  • 7.4. RF Generator

8. Renal Denervation Devices Market, by Disease Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Heart Failure
  • 8.4. Hypertension
  • 8.5. Renal Failure

9. Renal Denervation Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Care Centers
  • 9.3. Diagnostic Centers & Hospitals
  • 9.4. Research & Academia

10. Americas Renal Denervation Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Renal Denervation Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Renal Denervation Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
    • 13.3.2. FDA Approves Verve Medical's IDE Renal Pelvic Denervation Trial
    • 13.3.3. Korean Startup Kalos Gets USD 3.5 Million Grant to Develop Renal Denervation Device for hypertension Treatment
    • 13.3.4. Renal Denervation Using Ultrasound Ablation in Treatment-Resistant Hypertension is Being Evaluated for Early Benefit Assessment in Germany
    • 13.3.5. Andera Partners Invests in SoniVie, a Medtech Company Developing a Promising Device for the Treatment of Hypertension
    • 13.3.6. Transitional Coverage for Renal Denervation Catheter SYMPLICITY SPYRAL from Medtronic in France
    • 13.3.7. Shanghai Golden Leaf Med Tec Co., Ltd Secures Hundreds of Mns of CNY in Series C Round
    • 13.3.8. SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with other SPYRAL HTN Renal Denervation Trials
    • 13.3.9. SoniVie Receives IDE Approval from FDA for its Pilot Study to Treat Hypertension with its Renal Artery Denervation TIVUS Technology
    • 13.3.10. Ablative Solutions Raises USD 91.4 Million in Series D Financing Round
    • 13.3.11. Clinical Accelerator Announces Collaboration with Verve Medical to Conduct an Early Human Feasibility Study for Treatment-Resistant Hypertension

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. RENAL DENERVATION DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 15. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 17. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 19. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 23. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2023 (USD THOUSAND)
  • TABLE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2024-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 6. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 16. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 18. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 20. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 22. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 24. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 26. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 28. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 30. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 32. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 33. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 34. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 35. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 36. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 37. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 38. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 39. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 40. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 41. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 42. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 43. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 44. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 45. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 46. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 47. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 48. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 49. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 50. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 51. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 52. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 53. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 54. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 55. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 56. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 57. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 58. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 59. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 60. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 61. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 62. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 63. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 64. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 65. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 66. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 67. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 68. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 69. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 70. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 71. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 72. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 73. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 74. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 75. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 76. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 77. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 78. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 79. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 80. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 81. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 82. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 83. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 84. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 85. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 86. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 87. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 88. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 89. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 90. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 91. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 92. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 93. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 94. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 95. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 96. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 97. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 98. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 99. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 100. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 101. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 102. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 103. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 104. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 105. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 106. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 107. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 108. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 109. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 110. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 111. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
  • TABLE 112. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
  • TABLE 113. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 114. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 115. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 116. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 117. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 118. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 119. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 120. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 121. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 122. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 123. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 124. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 125. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 126. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 127. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 128. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 129. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 130. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 131. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 132. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 133. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 134. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 135. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 136. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 137. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 138. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 139. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 140. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 141. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 142. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 143. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 144. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 145. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 146. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 147. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 148. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 149. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 150. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 151. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 152. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 153. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 154. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 155. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 156. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 157. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 158. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 159. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 160. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 161. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 162. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 163. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 164. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 165. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 166. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 167. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 168. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 169. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 170. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 171. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 172. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 173. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 174. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 175. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 176. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 177. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 178. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 179. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 180. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 181. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 182. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 183. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 184. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 185. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 186. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 187. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 188. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 189. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 190. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 191. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 192. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 193. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 194. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 195. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 196. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 197. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 198. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 199. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 200. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 201. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 202. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 203. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 204. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 205. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 206. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 207. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 208. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 209. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 210. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 211. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 212. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 213. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 214. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 215. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 216. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 217. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 218. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 219. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 220. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 221. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 222. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 223. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 224. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 225. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 226. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 227. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 228. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 229. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 230. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 231. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 232. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 233. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 234. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 235. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 236. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 237. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 238. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 239. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 240. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 241. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 242. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 243. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 244. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 257. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 258. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 259. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 260. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 261. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 262. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 263. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 264. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 265. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 266. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 267. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 268. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 269. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 270. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 271. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 272. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 273. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 274. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 275. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 276. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 277. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 278. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 279. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 280. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 281. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 282. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 283. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 284. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 285. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 286. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 287. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 288. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 289. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 290. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 291. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 292. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 293. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 294. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 295. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 296. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 297. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 298. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 299. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 300. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 301. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 302. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 303. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 304. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 305. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 306. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 307. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 308. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 309. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 310. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 311. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 312. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 313. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 314. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 315. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 316. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 317. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 318. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 319. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 320. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 321. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 322. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 323. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 324. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 325. ITALY RENAL DENERVATION DEVICES MARKE